Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1986-01-16
1988-03-15
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514256, A61K 3138, A61K 31505
Patent
active
047313633
ABSTRACT:
The present disclosure relates to the use of thromboxane synthase inhibitors as antiobesity agents and insulin lowering agents. Such compounds fall into a variety of classes among which are 1-substituted imidazoles, 4-substituted imidazoles, 3-substituted pyridines, 3-substituted indoles, 4-substituted pyrimidines, 5-substituted tetrazoles, pyrazolidines, quinazolines, and substituted xanthene carboxylic acids.
REFERENCES:
patent: 3637731 (1972-01-01), Johnson
patent: 3821415 (1974-06-01), Heyes et al.
patent: 3867539 (1975-02-01), Henkin
patent: 3880871 (1975-04-01), Haugwitz et al.
patent: 3991201 (1976-11-01), Heeres et al.
patent: 3996366 (1976-12-01), Baker et al.
Chem. Abst. 82:118,787(h) (1975)-Aeberli et al.
Chem. Abst. 74:96456(e) (1971)-Lefebvre et al.
Chem. Abst. 76:108,708(v) (1972)-Malaisse.
The Merck Index, 9th ed., item 4845-1976-Meader Co., Diabetologia 4, 370-374 (1968).
Hamilton James G.
Sullivan Ann C.
Tobias Lawrence D.
Triscari Joseph
Boxer Matthew
Hoffmann-La Roche Inc.
Leon Bernard S.
Robinson Douglas W.
Saxe Jon S.
LandOfFree
Thromboxane synthase inhibitors as insulin lowering agents and a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thromboxane synthase inhibitors as insulin lowering agents and a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thromboxane synthase inhibitors as insulin lowering agents and a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1926631